BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 38061333)

  • 1. Protein-centric omics analysis reveals circulating complements linked to non-viral liver diseases as potential therapeutic targets.
    Shi Y; Dong H; Sun S; Wu X; Fang J; Zhao J; Han J; Li Z; Wu H; Liu L; Wu W; Tian Y; Yuan G; Fan X; Xu C
    Clin Mol Hepatol; 2024 Jan; 30(1):80-97. PubMed ID: 38061333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Causal effect of autoimmune liver diseases on cancer: Meta-analyses of cohort studies and Mendelian randomization study.
    Gu D; Zhang M; Wang Y; Bai Y; Wang X; Deng G
    Liver Int; 2022 Oct; 42(10):2216-2226. PubMed ID: 35775855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement factor H-related proteins CFHR2 and CFHR5 represent novel ligands for the infection-associated CRASP proteins of Borrelia burgdorferi.
    Siegel C; Hallström T; Skerka C; Eberhardt H; Uzonyi B; Beckhaus T; Karas M; Wallich R; Stevenson B; Zipfel PF; Kraiczy P
    PLoS One; 2010 Oct; 5(10):e13519. PubMed ID: 20975954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Causal effects of gut microbiome on autoimmune liver disease: a two-sample Mendelian randomization study.
    Fu Y; Li J; Zhu Y; Chen C; Liu J; Gu S; Zheng Y; Li Y
    BMC Med Genomics; 2023 Oct; 16(1):232. PubMed ID: 37789337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic evidence of the causal relationship between chronic liver diseases and musculoskeletal disorders.
    Lu Z; Li X; Qi Y; Li B; Chen L
    J Transl Med; 2024 Feb; 22(1):138. PubMed ID: 38321551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations of non-alcoholic fatty liver disease and cirrhosis with liver cancer in European and East Asian populations: A Mendelian randomization study.
    Deng Y; Huang J; Wong MCS
    Cancer Rep (Hoboken); 2024 Jan; 7(1):e1913. PubMed ID: 37840448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between type 2 diabetes mellitus and chronic liver diseases: evidence from a Mendelian ranldomization study in Europeans and East Asians.
    Zhao Y; Li D; Shi H; Liu W; Qiao J; Wang S; Geng Y; Liu R; Han F; Li J; Li W; Wu F
    Front Endocrinol (Lausanne); 2024; 15():1338465. PubMed ID: 38495785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of complement activation in autoimmune liver disease.
    Biewenga M; Farina Sarasqueta A; Tushuizen ME; de Jonge-Muller ESM; van Hoek B; Trouw LA
    Autoimmun Rev; 2020 Jun; 19(6):102534. PubMed ID: 32234403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Causal impacts of educational attainment on chronic liver diseases and the mediating pathways: Mendelian randomization study.
    Wang Y; Kong L; Ye C; Dou C; Zheng J; Xu M; Xu Y; Li M; Zhao Z; Lu J; Chen Y; Wang W; Ning G; Bi Y; Wang T
    Liver Int; 2023 Nov; 43(11):2379-2392. PubMed ID: 37409353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic link between primary sclerosing cholangitis and thyroid dysfunction: a bidirectional two-sample Mendelian randomization study.
    Zhang W; Lang R
    Front Immunol; 2023; 14():1276459. PubMed ID: 37928559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigating the shared genetic architecture between primary sclerosing cholangitis and inflammatory bowel diseases: a Mendelian randomization study.
    Dong X; Gong LL; Hong MZ; Pan JS
    BMC Gastroenterol; 2024 Feb; 24(1):77. PubMed ID: 38373892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential functions and causal associations of VPS29 in hepatocellular carcinoma: a bioinformatic and Mendelian randomization study.
    Yao YQ; Lv JL
    Eur Rev Med Pharmacol Sci; 2023 Oct; 27(20):9586-9600. PubMed ID: 37916325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-density lipoprotein cholesterol and risk of hepatocellular carcinoma: a Mendelian randomization and mediation analysis.
    Cao J; Wang Z; Zhu M; Huang Y; Jin Z; Xiong Z
    Lipids Health Dis; 2023 Jul; 22(1):110. PubMed ID: 37525197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overlap syndrome of autoimmune hepatitis and primary biliary cholangitis complicated with atypical hepatocellular carcinoma: a case report.
    Surdea-Blaga T; Cărăguț RL; Caraiani C; Spârchez Z; Al Hajjar N; Dumitrașcu DL
    J Med Case Rep; 2023 Jul; 17(1):328. PubMed ID: 37488645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic association of interleukin-6 polymorphism (-174 G/C) with chronic liver diseases and hepatocellular carcinoma.
    Giannitrapani L; Soresi M; Balasus D; Licata A; Montalto G
    World J Gastroenterol; 2013 Apr; 19(16):2449-55. PubMed ID: 23674845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and predictors of hepatocellular carcinoma in patients with autoimmune hepatitis.
    Colapietro F; Maisonneuve P; Lytvyak E; Beuers U; Verdonk RC; van der Meer AJ; van Hoek B; Kuiken SD; Brouwer JT; Muratori P; Aghemo A; Carella F; van den Berg AP; Zachou K; Dalekos GN; Di Zeo-Sánchez DE; Robles M; Andrade RJ; Montano-Loza AJ; van den Brand FF; Slooter CD; Macedo G; Liberal R; de Boer YS; Lleo A; ;
    J Hepatol; 2024 Jan; 80(1):53-61. PubMed ID: 37802188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced circulating transforming growth factor beta 1 is causally associated with an increased risk of hepatocellular carcinoma: a mendelian randomization meta-analysis.
    Lu WQ; Qiu JL; Huang ZL; Liu HY
    Oncotarget; 2016 Dec; 7(51):84695-84704. PubMed ID: 27835897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Causal associations between gut microbiota and Cholestatic liver diseases: a Mendelian randomization study.
    Yang J; Ma G; Wang K; Yang H; Jiang S; Fan Q; Zhou X; Guo G; Han Y
    Front Med (Lausanne); 2024; 11():1342119. PubMed ID: 38327703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary sclerosing cholangitis causally affects kidney function decline: A Mendelian randomization study.
    Cho JM; Koh JH; Kim SG; Lee S; Kim Y; Cho S; Kim K; Kim YC; Han SS; Lee H; Lee JP; Joo KW; Lim CS; Kim YS; Kim DK; Park S
    J Gastroenterol Hepatol; 2024 Jan; 39(1):185-192. PubMed ID: 37726875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic-dysfunction associated steatotic liver disease-related diseases, cognition and dementia: A two-sample mendelian randomization study.
    Li YS; Xia YG; Liu YL; Jiang WR; Qiu HN; Wu F; Li JB; Lin JN
    PLoS One; 2024; 19(2):e0297883. PubMed ID: 38422093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.